AVANIR Pharmaceuticals, Inc.
| Nasdaq: AVNR
AVANIR Pharmaceuticals, Inc. is a pharmaceutical company focused on acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders. The company's products are NUEDEXTA, AVP-923, Deuterated Dextromethorphan, ABREVA and Thravixa. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA.